恩瑞格国内售价多少？

Probably most people have never heard of thalassemia. This disease is a hereditary disease that is very common in my country and Southeast Asia. Generally speaking, the symptoms of this disease are the same as anemia, but if not treated in time, it can be life-threatening. Most of these patients in the country receive blood transfusion and iron removal treatment. However, the new thalassemia drug (Deferasirox) produced by Swiss Novartis changed our treatment options after it came on the market.

For the thalassemia/and aplastic anemia group, surgical transplantation can be used to treat it, but the risk is too high and the success rate is low. Most of them are treated with regular blood transfusion + iron elimination, which means that they need to be hospitalized for blood transfusion every month. The disadvantage of blood transfusion is that it directly leads to increased ferritin and iron accumulation. The harm is serious damage to the body's liver and heart, which is irreversible. Fortunately, in addition to the above two methods, we also have Deferasirox produced by Novartis. It is not only convenient to take, but also simple and effective in treatment. It is currently the most common treatment plan accepted by many patients with thalassemia.

How much does Deferasirox sell for in the country?

The price of Deferasirox in China is relatively high, with a box costing about $2,000. The dosage method is to take 20mg to 40mg Enreg/Delasirox for 1kg of body weight. Taking 30mg/kg as an example, a normal person weighing 60kg would cost more than 24,000$ to take Deferasirox for a month. Ordinary families would accept this price.

Enriga, produced by cipla in India, has a specification of 500mg*30 tablets/box and sells for about RMB 500. The original drug Deferasirox launched by Novartis in India is 400mg*30 tablets/box, priced at approximately RMB 700.

When patients purchase the Indian version of Deferasirox, they first go to India to buy it in person, find a hospital doctor to write a prescription, and then take the medicine back to their country for treatment. However, this approach is time-consuming, costly, and not very feasible. The second is to find domestic overseas medical service agencies (such as Medical Companion Travel), who will translate the cases, contact experienced doctors in Indian hospitals to write prescriptions, and deliver the medicines to patients by direct mail from Indian pharmaceutical factories. They will also guide and answer questions for patients during the medication. This is currently the most economical and feasible solution.